Immutep Statistics
NASDAQ: IMMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.11-0.31 (-9.06%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Immutep by the numbers
Immutep has a market capitalization of $22.9 million based on 7.37M shares outstanding. With trailing EPS of $-7.30, Immutep is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.6% below its 50-day average and 75.8% below its 200-day average.
Average daily trading volume is 26.07K shares, or about $81,062 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMMP valuation vs. peer median
| Metric | IMMP | Peer median | Difference |
|---|---|---|---|
| Market cap | $22.92M | $23.23M | -1% |
| Avg. volume | 26.07K | 158.44K | -84% |
Peer median across 8 companies: RMTI, IXHL, ABVC, SCYX, CRVO, LITS, AARD, RNAZ.
Valuation
- Market cap
- $22.92M
- EPS (TTM)
- $-7.30
- Shares outstanding
- 7.37M
Price and trading
- Previous close
- 3.42
- Open
- 3.41
- Day range
- 3.09 – 3.41
- 52-week range
- 2.66 – 70.60
- 52-week change
- +80.81%
- Beta
- —
- Volume
- 44.77K
- Average volume
- 26.07K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 3, 2026
Additional statistics
- Market Cap
- 22.92M
- Forward Pe
- -0.96
- Eps
- -7.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 70.60
- Week52 Low
- 2.66
- Avg Volume
- 26,065.00
- Shares Outstanding
- 7.37M
- Ma50
- 4.02
- Ma200
- 12.83
- Earnings Date
- Sep 3, 2026
- Pct From52w High
- -95.59%
- Pct From52w Low
- 16.92%